Increased BCR responsiveness in B cells from patients with chronic GVHD.
about
B cells in chronic graft-versus-host diseaseThe Biology of Chronic Graft-versus-Host Disease: A Task Force Report from the National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host DiseaseIncreased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliteransAberrant B-cell homeostasis in chronic GVHDImatinib mesylate for the treatment of steroid-refractory sclerotic-type cutaneous chronic graft-versus-host disease.Inhibition of BTK and ITK with Ibrutinib Is Effective in the Prevention of Chronic Graft-versus-Host Disease in MiceTargeting Syk-activated B cells in murine and human chronic graft-versus-host disease.Circulating T follicular helper cells with increased function during chronic graft-versus-host diseaseA combined biomarker and clinical panel for chronic graft versus host disease diagnosisGenetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility GenesTherapeutic benefits targeting B-cells in chronic graft-versus-host disease.National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report.TLR7/TLR9- and B Cell Receptor-Signaling Crosstalk: Promotion of Potentially Dangerous B Cells.Cellular and molecular mechanisms in graft-versus-host disease.Mechanistic approaches for the prevention and treatment of chronic GVHD.Novel targets in the treatment of chronic graft-versus-host disease.Durable responses to ibrutinib in patients with relapsed CLL after allogeneic stem cell transplantation.Mesenchymal Stem Cells May Ameliorate Nephrotic Syndrome Post-Allogeneic Hematopoietic Stem Cell Transplantation-Case ReportIbrutinib for chronic graft-versus-host disease after failure of prior therapy.An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD.Changes in protein serum levels during stem cell transplantation.New and emerging therapies for acute and chronic graft versus host disease.B-cell targeting in chronic Graft-versus-Host disease.The Role of B Cell Targeting in Chronic Graft-Versus-Host Disease.SYK Inhibition Induces Apoptosis in Germinal Center-Like B Cells by Modulating the Antiapoptotic Protein Myeloid Cell Leukemia-1, Affecting B-Cell Activation and Antibody Production.Graft versus Host Disease: From Basic Pathogenic Principles to DNA Damage Response and Cellular Senescence.Impaired bone marrow B-cell development in mice with a bronchiolitis obliterans model of cGVHDHow ibrutinib, a B-cell malignancy drug, became an FDA-approved second-line therapy for steroid-resistant chronic GVHD
P2860
Q26861706-475C11E8-E212-47A0-A6B4-27C44312A44FQ28076264-7846D1BD-E6F8-42E2-B28F-013F41C3A4C3Q33781179-3ED36A04-064E-4654-B2CF-BDCFD59420EFQ35171251-2E249D20-F7D6-42F9-8DB2-49A578D5EE76Q35588726-F3D81731-E616-4964-847B-DBAE36989F3EQ35766798-10FC7949-1351-451F-B54B-AF152A190904Q35784522-B8C5BFCF-D525-4AF3-AB9D-674FCE36E6FCQ36920466-EC5A7298-97F0-4C8D-B2C1-8DF25D68B33EQ37601730-C76B337E-3738-4EAF-B274-AD1F3BDD34ADQ37734489-9A3914C0-2395-4CEE-8947-0B27F83C32CEQ38392246-85F1EE55-C714-4A78-8074-6ADEF5E0665CQ38405199-EF1A6CD3-4425-4938-977C-543D84D0FE1CQ38656329-4E55FAE6-4940-4FF1-924B-5CFDC0DD1037Q38661579-DD7B5924-7871-4C94-98E8-3D25ACAEC091Q39002166-CECA6C9A-D268-4028-BCAC-E711CE566132Q39023963-8FA879AF-5859-4C76-9641-D49F45271748Q40122845-ABA443CA-D8C2-4CAF-BBEB-0276054D3413Q41417888-23B5D855-D856-42C4-93E9-1DAD224E841EQ46428638-EE74ED53-2200-4CD6-93B4-A1DC5257B270Q47709978-19F62E19-D17F-427B-AF56-F83BEA6D4238Q47969259-9B399973-7680-4CE5-9522-FA6885A26239Q49238507-8794CAB3-C877-43C2-9E0E-FFC82315D9F5Q50044417-9FCD4111-6D5D-4926-822F-A77727DE812AQ52971841-FED49AFC-ABBB-458D-82E1-6B0111E60A0DQ54979506-F5858286-7C9D-4004-96E9-1895C9673BCBQ55045366-B4B52C54-183D-41D5-9526-F642E50FC269Q58723868-F9E4FF08-E2BD-4467-BEA7-F89E35FE80F2Q58782275-472EE2E2-465A-4789-96EE-F681CE6B9EAC
P2860
Increased BCR responsiveness in B cells from patients with chronic GVHD.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Increased BCR responsiveness in B cells from patients with chronic GVHD.
@en
Increased BCR responsiveness in B cells from patients with chronic GVHD.
@nl
type
label
Increased BCR responsiveness in B cells from patients with chronic GVHD.
@en
Increased BCR responsiveness in B cells from patients with chronic GVHD.
@nl
prefLabel
Increased BCR responsiveness in B cells from patients with chronic GVHD.
@en
Increased BCR responsiveness in B cells from patients with chronic GVHD.
@nl
P2093
P2860
P1433
P1476
Increased BCR responsiveness in B cells from patients with chronic GVHD.
@en
P2093
Allison M Deal
Andrew Sharf
David Rizzieri
Jenna Wooten
Jessica L Allen
Kristy L Richards
Madan Jagasia
Matthew S Fore
Mitchell E Horwitz
Nelson J Chao
P2860
P304
P356
10.1182/BLOOD-2013-10-533562
P407
P577
2014-02-14T00:00:00Z